Provided by Tiger Fintech (Singapore) Pte. Ltd.

CERo Therapeutics Holdings, Inc.

9.26
-0.2000-2.11%
Post-market: 9.22-0.0400-0.43%16:48 EDT
Volume:56.77K
Turnover:530.61K
Market Cap:4.78M
PE:0.00
High:9.57
Open:9.35
Low:9.22
Close:9.46
Loading ...
Jul 03, 2024

Correspondence

Form CORRESP - Correspondence
Jun 28, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jun 27, 2024

Correspondence

Form CORRESP - Correspondence
Jun 06, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jun 05, 2024

Correspondence

Form CORRESP - Correspondence
May 17, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
May 04, 2024

Major Issues Report

Form 8-K - Current report
May 01, 2024

Major Issues Report

Form 8-K - Current report
Apr 29, 2024

Correspondence

Form CORRESP - Correspondence
Apr 26, 2024

Correspondence

Form CORRESP - Correspondence
Apr 26, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Apr 10, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Apr 02, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Apr 02, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Feb 28, 2024

Major Issues Report

Form 8-K - Current report
Feb 27, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Feb 22, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 20, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]